You are here


An analysis of two databases found that measuring frailty could help predict mortality and functional status at six months or later after older adults undergo cardiac surgery.

Recent Headlines

Succeeding with Cancer: Using Imaging to Avoid Treatment-induced Heart Failure

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

Cryo vs. RF Ablation: Electrophysiologists Take a Tempered Approach

About one year ago, FIRE AND ICE trial investigators reported that cryoballoon ablation (cryo) performed as well as radiofrequency ablation (RF) as a treatment for patients with drug-refractory paroxysmal atrial fibrillation. But is “as good as” good enough to change practice? The answer may be emerging just now.

Dawn of a New Way: Answers & Actions for Adapting to MACRA & Value-based Care

2017 brought a new reality to the U.S. healthcare community. The Medicare Access and CHIP Reimbursement Act, or MACRA, is no longer just the law that repealed the sustainable growth rate. With its Quality Payment Program that defines complex new payment models, MACRA is the machine that is nudging clinicians and practices away from fee-for-service and into value-based healthcare.

As the transition begins, many clinicians feel confused as they straddle two payment systems in healthcare delivery. Paul N. Casale, MD, MPH, hosted a Cardiovascular Business roundtable discussion, where participants voiced questions on the minds of many, brainstormed answers and identified new opportunities for the cardiovascular community to lead.

Impella heart pump reduces risk of acute kidney injury in high-risk patients

Research from the University of Louisville has found that the Abiomed Impella 2.5 heart pump helps reduce the risk of acute kidney injury—even in patients with preexisting kidney disease—when physicians are trying to complete a high-risk percutaneous coronary intervention (HRPCI).

Siemens, HeartFlow create 3D heart models to treat coronary artery disease

Siemens Healthineers and medical technology company HeartFlow have collaborated on a comprehensive, noninvasive heart technology to help diagnose and manage patients who may have coronary artery disease (CAD).

AliveCor platform lets docs monitor heart patients to prevent stroke, atrial fibrillation

AliveCor has introduced Kardia Pro, a cloud-based software platform that allows physicians to monitor patients who use the corresponding mobile electrocardiogram, Kardia Mobile.

Adventist Health to use Lumedx’s cardiovascular software in facilities

As it enhances its cardiovascular care delivery, Altamonte Springs, Florida-based Adventist Health System will incorporate a new cardiovascular data intelligence and imaging software made by Lumedx in its facilities.

Amazon’s Alexa can now walk users through CPR

Amazon’s voice-activated Echo device can now give instructions to users on how to perform CPR, handle a heart attack and detect stroke signs, features that could help save lives.

Biotronik creates new online tool that identifies cardiac devices safe for MRI

Berlin-based Biotronik has created an online tool that advises physicians on the appropriate MR-conditional heart monitor or pacing or ICD system for patients.

Everist Health develops test that can predict heart disease risk

Everist Health, a health technology company based in Ann Arbor, Michigan, has launched a new test that predicts patients’ risk of developing cardiovascular disease, a preventative measure that could make a big different for susceptible patients.